PLIANT THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pliant Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q1 2024.
  • Pliant Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $445K, a 43.1% increase year-over-year.
  • Pliant Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.4M, a 27.1% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Interest Expense for 2023 was $1.27M, a 60.2% increase from 2022.
  • Pliant Therapeutics, Inc. annual Interest Expense for 2022 was $791K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.4M $445K +$134K +43.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.27M $320K +$3K +0.95% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.26M $317K +$16K +5.32% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.25M $319K +$146K +84.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.1M $311K +$311K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $791K $317K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $301K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $173K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.